CY1105456T1 - Χρηση σκιαγραφικων αντιδραστηριων στην παρασκευη ενος διαγνωστικου αντιδραστηριου για την απεικονιση του εντepικου αυλου - Google Patents

Χρηση σκιαγραφικων αντιδραστηριων στην παρασκευη ενος διαγνωστικου αντιδραστηριου για την απεικονιση του εντepικου αυλου

Info

Publication number
CY1105456T1
CY1105456T1 CY20061100565T CY061100565T CY1105456T1 CY 1105456 T1 CY1105456 T1 CY 1105456T1 CY 20061100565 T CY20061100565 T CY 20061100565T CY 061100565 T CY061100565 T CY 061100565T CY 1105456 T1 CY1105456 T1 CY 1105456T1
Authority
CY
Cyprus
Prior art keywords
lurma
entepical
imaging
preparation
diagnostic reagent
Prior art date
Application number
CY20061100565T
Other languages
English (en)
Inventor
Michael V. KNOO
Frederik Giesel
Hendrik Von Tengg-Kobligk
Jannis Radeleff
Original Assignee
Bracco Imaging S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT1999MI002735 external-priority patent/IT1315273B1/it
Priority claimed from IT2000MI000193A external-priority patent/IT1317816B1/it
Application filed by Bracco Imaging S.P.A. filed Critical Bracco Imaging S.P.A.
Publication of CY1105456T1 publication Critical patent/CY1105456T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/103—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA

Landscapes

  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)

Abstract

Χρήση σκιαγραφικών αντιδραστηρίων που αποβάλλονται από την ηπατοχολική οδό, για την παρασκευή ενός σκιαγραφικού αντιδραστηρίου για ενδοφλέβια χορήγηση, η οποία είναι χρήσιμη για την εξέταση μορφολογικών/ δομικών ή παθολογικών αλλοιώσεων, τροποποιήσεων και/ ή αλλαγών του εντερικού αυλού για μελέτες της χολικής κινητικής μεταφοράς.
CY20061100565T 1999-12-29 2006-05-02 Χρηση σκιαγραφικων αντιδραστηριων στην παρασκευη ενος διαγνωστικου αντιδραστηριου για την απεικονιση του εντepικου αυλου CY1105456T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT1999MI002735 IT1315273B1 (it) 1999-12-29 1999-12-29 Imaging del colon mediante contrastografia.
IT2000MI000193A IT1317816B1 (it) 2000-02-08 2000-02-08 Imaging del colon mediante contrastografia.
PCT/EP2000/013069 WO2001049326A1 (en) 1999-12-29 2000-12-21 Use of contrast agents in the manufacture of diagnostic agent for the visualisation of the intestinal lumen

Publications (1)

Publication Number Publication Date
CY1105456T1 true CY1105456T1 (el) 2010-04-28

Family

ID=26331700

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061100565T CY1105456T1 (el) 1999-12-29 2006-05-02 Χρηση σκιαγραφικων αντιδραστηριων στην παρασκευη ενος διαγνωστικου αντιδραστηριου για την απεικονιση του εντepικου αυλου

Country Status (12)

Country Link
US (1) US20030113267A1 (el)
EP (1) EP1251875B1 (el)
JP (1) JP4798919B2 (el)
CN (1) CN1302814C (el)
AT (1) ATE320272T1 (el)
AU (1) AU2842901A (el)
CY (1) CY1105456T1 (el)
DE (1) DE60026743T2 (el)
DK (1) DK1251875T3 (el)
ES (1) ES2259299T3 (el)
PT (1) PT1251875E (el)
WO (1) WO2001049326A1 (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7260174B2 (en) 2004-09-13 2007-08-21 General Electric Company Direct conversion energy discriminating CT detector with over-ranging correction
US7606347B2 (en) * 2004-09-13 2009-10-20 General Electric Company Photon counting x-ray detector with overrange logic control
US7209536B2 (en) * 2004-11-19 2007-04-24 General Electric Company CT colonography system
US7599465B2 (en) 2004-11-19 2009-10-06 General Electric Company Detection of thrombi in CT using energy discrimination
US7382853B2 (en) 2004-11-24 2008-06-03 General Electric Company Method and system of CT data correction
US7583779B2 (en) * 2004-11-24 2009-09-01 General Electric Company System and method for acquisition and reconstruction of contrast-enhanced, artifact-reduced CT images
US7613274B2 (en) * 2007-11-16 2009-11-03 General Electric Company Method and system of energy integrating and photon counting using layered photon counting detector

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4999445A (en) * 1988-06-10 1991-03-12 The Regents Of The University Of California Contrast agents for magnetic resonance imaging of the small intestine and hepatobiliary system
US6039931A (en) * 1989-06-30 2000-03-21 Schering Aktiengesellschaft Derivatized DTPA complexes, pharmaceutical agents containing these compounds, their use, and processes for their production
US5695739A (en) * 1989-06-30 1997-12-09 Schering Aktiengesellschaft Derivatized DTPA complexes, pharmaceutical agents containing these compounds, their use, and processes for their production
DE4035760A1 (de) * 1990-11-08 1992-05-14 Schering Ag Mono-n-substituierte 1,4,7,10-tetraazacyclododecan-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
US5245282A (en) * 1991-06-28 1993-09-14 University Of Virginia Alumni Patents Foundation Three-dimensional magnetic resonance imaging
EP0598837A4 (en) * 1991-08-09 1994-07-13 Univ California Amino acid, ester and/or catechol contrast agents for mri.
IT1252145B (it) * 1991-11-29 1995-06-05 Bracco Ind Chimica Spa Metodo e formulazioni adatte a migliorare lo studio degli organi cavi nell'uomo
WO1993015093A1 (en) * 1992-01-29 1993-08-05 The Regents Of The University Of California Specific contrast agents for magnetic resonance imaging of the small intestine and hepatobiliary system
US5401493A (en) * 1993-03-26 1995-03-28 Molecular Biosystems, Inc. Perfluoro-1H,-1H-neopentyl containing contrast agents and method to use same
IT1269839B (it) * 1994-05-26 1997-04-15 Bracco Spa Coniugati di acidi biliari, loro derivati con complessi metallici e relativi usi
JP4432000B2 (ja) * 1996-12-23 2010-03-17 ブラッコ・リサーチ・ソシエテ・アノニム 患者の消化管の視覚化におけるｍｒｉ造影の増加用組成物

Also Published As

Publication number Publication date
EP1251875A1 (en) 2002-10-30
US20030113267A1 (en) 2003-06-19
EP1251875B1 (en) 2006-03-15
PT1251875E (pt) 2006-07-31
AU2842901A (en) 2001-07-16
JP2003519200A (ja) 2003-06-17
DK1251875T3 (da) 2006-07-24
CN1302814C (zh) 2007-03-07
WO2001049326A1 (en) 2001-07-12
ES2259299T3 (es) 2006-10-01
DE60026743D1 (de) 2006-05-11
CN1413119A (zh) 2003-04-23
ATE320272T1 (de) 2006-04-15
DE60026743T2 (de) 2006-08-17
JP4798919B2 (ja) 2011-10-19

Similar Documents

Publication Publication Date Title
CY1105456T1 (el) Χρηση σκιαγραφικων αντιδραστηριων στην παρασκευη ενος διαγνωστικου αντιδραστηριου για την απεικονιση του εντepικου αυλου
ES2651343T3 (es) Un producto de vendaje
CY1105707T1 (el) Συνδυασμοι φορμοτερολης και ενος αλατος τριοτροπιου
CY1114132T1 (el) Γαστροανθεκτικες φαρμακοτεχνικες μορφες που περιεχουν ριφαξιμινη
FR15C0033I2 (fr) Support macromoleculaire sur base de dextran pour l'administration d'un agent diagnostique ou therapeutique
NO20014769D0 (no) Preparat for behandling og diagnose av bryst cancer og fremgangsmåter for anvendelse derav
BR9607136A (pt) Agentes de contraste para formação de imagens para diagnóstico com retenção de sangue aumentada
NO20016427L (no) Blandinger og fremgangsmåter for behandling av diagnose av lungekreft
BR0110748A (pt) Plataforma de nanodispositivo multifuncional
DE50002860D1 (de) Spreizbares medizinisches instrument, insbesondere laryngoskop
DE60013092D1 (de) Ballonkatheter für den Magen mit verbesserter Ballonorientierung
BRPI0515175A (pt) método para radiofluoração, composto, composição radiofarmacêutica, uso de um conjugado radiorrotulado ou um sal do mesmo, método para diagnose ou formação de imagem in vivo de uma doença ou condição associada com a angiogênese, e, método para monitorar o efeito do tratamento de um corpo humano ou animal com um medicamento para combater uma condição associada com cáncer
ES2136673T3 (es) Utilizacion del factor de crecimiento de los queratinocitos para la obtencion de medicamentos.
CL2004001126A1 (es) Complejos de polimeros en cascada y sus composiciones farmaceuticas, utiles para la preparacion de agentes de diagnostico por nmr.
WO2005048950A3 (en) Tumor and infectious disease therapeutic compositions
DE820303T1 (de) p277 PEPTIDANALOGE, PHARMAZEUTISCHE ZUSAMMENSTELLUNG DAVON ZUR BEHANDLUNG UND DIAGNOSE VON DIABETES
AU2001291225A1 (en) Analysis of hiv-1 coreceptor use in the clinical care of hiv-1-infected patients
CN108404141A (zh) 一种基于近红外ii区量子点的骨靶向给药系统及其制备方法和应用
NO964451L (no) Röntgenkontrastblandinger inneholdende farmasöytisk akseptable leirer
BR0207327A (pt) Amino derivados de biotina e seus conjugados com agentes quelantes macrocìclicos
DE69724761D1 (de) Biotinylierter antikörper mit verminderter positiver nettoladung und toxin, medikament oder chelat
SEO et al. Endoscopic removal of gastrointestinal foreign bodies in 3 newborn infants immediately after birth
RU2002117246A (ru) Способ диагностики криптоспоридиоза
BR0016469A (pt) Composição para melhorar a resposta proliferativa durante a adaptação do trato gastrointestinal e uso na sìndrome do intestino delgado
YOO et al. Clinical analysis of abdominal actinomycosis: 8 cases